Evidence map›Paper›PMID 20864807›Full record

ReviewPrion

Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C).

Andrew C Gill, Sonya Agarwal, Teresa J T Pinheiro, James F Graham

Open access · bronzeAbstract readReview
In one paragraph

Review in Prion. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Prions: Beyond a Single Protein.Clinical microbiology reviews · 2016
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Andrew C GillThe Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush Veterinary Centre, Edinburgh, UK. Andrew.gill@roslin.ed.ac.uk
Sonya Agarwal
Teresa J T Pinheiro
James F Graham
Roslin Institute · GBUniversity of Edinburgh · GBUniversity of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/A/00001663Biotechnology and Biological Sciences Research Council BBS/E/D/05241338
6 · The paper itself

Abstract

To understand why cross-species infection of prion disease often results in inefficient transmission and reduced protein conversion, most research has focused on defining the effect of variations in PrP primary structures, including sequence compatibility of substrate and seed. By contrast, little research has been aimed at investigating structural differences between different variants of PrP(C) and secondary structural requirements for efficient conversion. This is despite a clear role for molecular chaperones in formation of prions in non-mammalian systems, indicating the importance of secondary/tertiary structure during the conversion process. Recent data from our laboratory on the cellular location of disease-specific prion cofactors supports the critical role of specific secondary structural motifs and the stability of these motifs in determining the efficiency of disease-specific prion protein conversion. In this paper we summarize our recent results and build on the hypothesis previously suggested by Wuthrich and colleagues, that stability of certain regions of the prion protein is crucial for protein conversion to abnormal isoforms in vivo. It is suggested that one role for molecular cofactors in the conversion process is to stabilize PrP(C) structure in a form that is amenable for conversion to PrP(Sc).

Indexed as

AnimalsCoenzymesHumansProtein FoldingProtein StabilityPrPC ProteinsPrPSc ProteinsSpecies SpecificityCoenzymesPrPC ProteinsPrPSc Proteins

Identifiers

PMID20864807
PMCPMC3268955
OpenAlexW2115047528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.